A carregar...
A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
In light of the favorable outcomes of few small, non-randomized clinical studies, the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to Hydroxychloroquine (HCQ) for hospitalized coronavirus disease 2019 (COVID-19) patients. In fact, subsequent clinical studies wit...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355808/ https://ncbi.nlm.nih.gov/pubmed/32549293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061867 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|